Reuters logo
Sanofi says dengue vaccine effective in trial
July 25, 2012 / 5:27 AM / 5 years ago

Sanofi says dengue vaccine effective in trial

PARIS, July 25 (Reuters) - Sanofi Pasteur, the vaccines division of Sanofi, said on Wednesday that its dengue vaccine candidate proved effective in a study in fighting the disease, which it described as a threat to almost 3 billion people.

“The results confirm the excellent safety profile of the vaccine candidate,” Sanofi said in a statement, referring to a trial carried out in Thailand.

The full data are being reviewed by scientific experts and public health officials, with detailed results to be published later this year, Sanofi said.

Large-scale late-stage Phase III dengue vaccine clinical studies with 31,000 participants are under way in 10 countries in Asia and Latin America, the company added. (Reporting by James Regan; Editing by Nick Macfie)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below